A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

Clinical trial NCT07000357 · RECRUITING

Trial details

NCT number: NCT07000357
Sponsor: AstraZeneca
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiovascular Disease

Start date: 2025-06-04
Primary completion: 2029-10-26
Enrollment: 15100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.